Automate Your Wheel Strategy on MDT
With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDT
- Rev/Share 26.6854
- Book/Share 37.557
- PB 2.521
- Debt/Equity 0.5974
- CurrentRatio 2.0141
- ROIC 0.0619
- MktCap 120840942419.0
- FreeCF/Share 4.1378
- PFCF 22.7873
- PE 25.9042
- Debt/Assets 0.3145
- DivYield 0.0299
- ROE 0.0962
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | MDT | Wolfe Research | Underperform | Peer Perform | -- | -- | June 30, 2025 |
| Initiation | MDT | Leerink Partners | -- | Outperform | -- | $110 | June 16, 2025 |
| Upgrade | MDT | Citigroup | Neutral | Buy | $92 | $107 | March 4, 2025 |
| Upgrade | MDT | RBC Capital Mkts | Sector Perform | Outperform | $98 | $105 | Oct. 10, 2024 |
| Reiterated | MDT | Oppenheimer | -- | Perform | $92 | $94 | Aug. 21, 2024 |
News
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
5 Dividend Aristocrats Are Perfect for Boomers Seeking Growth and Income
Published: October 15, 2025 by: 24/7 Wall Street
Sentiment: Positive
While reaching retirement age can be both a blessing and a curse, relying on the U.S.
Read More
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Medtronic plc - Special Call
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc - Special Call Company Participants Ryan Weispfenning - VP & Head of Investor Relations Emily Elswick Conference Call Participants Ryan Zimmerman - BTIG, LLC, Research Division Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Christopher Pasquale - Nephron Research LLC Shagun Singh Chadha - RBC Capital Markets, Research Division Michael Polark - Wolfe Research, LLC Danielle Antalffy Presentation Ryan Weispfenning VP & Head of Investor Relations Okay. Hello, everyone.
Read More
Here's Why Medtronic (MDT) is a Strong Value Stock
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Published: September 24, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're glad to have the Medtronic CFO, Thierry Pieton, here with us. So welcome.
Read More
Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
Read More
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Read More
Medtronic: Buy This Dividend Aristocrat While It's Good Value
Published: September 17, 2025 by: Seeking Alpha
Sentiment: Positive
Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and Diabetes segments. The upcoming diabetes segment spinoff is expected to improve operating margins and reinforce MDT's growth trajectory.
Read More
1 Reason Every Investor Should Know About Medtronic (MDT)
Published: September 17, 2025 by: The Motley Fool
Sentiment: Neutral
The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite an event when a new stock joins this very limited and exclusive club.
Read More
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
Published: September 15, 2025 by: PRNewsWire
Sentiment: Neutral
Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the initiation of a pivotal study evaluating the use of elevated and personalized cardiac pacing rates for the treatment of patients with Heart Failure with preserved Ejection Fraction (ELEVATE-HFpEF, NCT06678841).
Read More
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
Published: September 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
Read More
Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Published: September 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Okay. Good morning.
Read More
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Published: September 04, 2025 by: PRNewsWire
Sentiment: Neutral
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. , Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo™ robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.
Read More
Medtronic executives to speak at upcoming investor conferences
Published: August 29, 2025 by: PRNewsWire
Sentiment: Neutral
GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m.
Read More
ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.
Read More
Here's Why Medtronic (MDT) is a Strong Momentum Stock
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
The Best High-Yield Healthcare Stock to Invest $1,000 in Right Now
Published: August 22, 2025 by: The Motley Fool
Sentiment: Neutral
I happily own stock in Medtronic (MDT -2.25%), one of the largest medical device makers in the world. Of late, the company is struggling through a rough patch that has Wall Street worried about the future.
Read More
Medtronic: Earnings Are Solid, New Board Additions Add Intrigue
Published: August 21, 2025 by: Seeking Alpha
Sentiment: Positive
Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involvement and new board appointments could drive operational improvements and strategic divestitures, echoing past success at Cardinal Health. Valuation is attractive on a PEG basis, but I remain on hold, awaiting clear evidence of sustainable earnings momentum and operational execution.
Read More
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings
Published: August 20, 2025 by: Benzinga
Sentiment: Positive
Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.
Read More
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Medtronic: The Opportunity Gets Healthier for Income Investors
Published: August 19, 2025 by: MarketBeat
Sentiment: Positive
Medtronic's NYSE: MDT FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that includes accelerating business growth, improving profitability, and reversing the stock price action.
Read More
Activist investor Elliott push spurs changes at Medtronic
Published: August 19, 2025 by: CNBC Television
Sentiment: Positive
Medical device maker Medtronic is making changes to its board after Elliott Investment Management became one of its largest shareholders. CNBC's David Faber breaks down the details.
Read More
Medtronic plc (MDT) Q1 2026 Earnings Call Transcript
Published: August 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Q1 2026 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Geoffrey Straub Martha - Chairman of the Board & CEO Michael Marinaro - Executive VP & President of Medical Surgical Portfolio and Americas Que Thanh Dallara - Executive VP & President Diabetes Operating Unit Ryan Weispfenning - VP & Head of Investor Relations Thierry Pieton - Executive VP & CFO Conference Call Participants Anthony Charles Petrone - Mizuho Securities USA LLC, Research Division Joanne Karen Wuensch - Citigroup Inc. Exchange Research Joshua Thomas Jennings - TD Cowen, Research Division Lawrence H. Biegelsen - …
Read More
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medtronic tops on Q1 earnings and revenues, raises full-year EPS outlook, but shares dip on board changes.
Read More
Medtronic (MDT) is a Top-Ranked Growth Stock: Should You Buy?
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Compared to Estimates, Medtronic (MDT) Q1 Earnings: A Look at Key Metrics
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Buy or Sell Medtronic Stock Now?
Published: August 18, 2025 by: Forbes
Sentiment: Neutral
Medtronic (NYSE:MDT) will report earnings on Tuesday, August 19, 2025. Over the last five years, the stock's next-day move following results has been highly unpredictable: it posted a positive one-day return in 50% of instances (median gain of 2.5%) and a negative one-day return in the other 50% (median loss of -3.8%).
Read More
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Published: August 18, 2025 by: Benzinga
Sentiment: Neutral
Medtronic plc MDT will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.
Read More
Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.
Read More
About Medtronic plc (MDT)
- IPO Date 1973-05-02
- Website https://www.medtronic.com
- Industry Medical - Devices
- CEO Geoffrey Straub Martha
- Employees 95000